MOPE Clinic says blood pressure monitoring matters as testosterone safety guidance changes

MOPE Clinic is urging men considering testosterone therapy to discuss blood pressure, cardiovascular history and sleep concerns with a healthcare professional. The clinic says FDA safety updates and newer trial data show the need for more individualized monitoring, not less.

Why it matters: - Testosterone therapy is a common topic for men asking about energy, sexual health and body composition. - MOPE Clinic says blood pressure and cardiovascular risk should be part of every testosterone conversation. - The FDA has updated testosterone safety information, making monitoring more important for patients and clinicians. - Men with hypertension, sleep problems or other cardiovascular risks may need a more individualized evaluation before or during treatment.

What happened: - MOPE Clinic published new educational guidance in Metairie, Louisiana, focused on testosterone, blood pressure and overall cardiovascular health. - The clinic is encouraging patients to discuss symptoms, lab results and medical history with their healthcare providers. - The guidance comes as FDA labeling for testosterone products has changed after newer cardiovascular and blood pressure data. - MOPE Clinic also pointed readers to additional educational material and invited patients to call 504-265-5491 or email info@mopeclinic.com for information. - The clinic shared a social media page for updates.

The details: - In February 2025, the FDA announced class-wide labeling changes for testosterone products. - The FDA removed boxed-warning language about an increased risk of adverse cardiovascular outcomes. - The FDA also required testosterone products to include information about increased blood pressure. - The FDA’s action followed review of the TRAVERSE cardiovascular outcomes trial and required ambulatory blood pressure monitoring studies. - MOPE Clinic said low testosterone and high blood pressure can occur together, but one does not prove the other caused it. - Age, body composition, sleep, illness, medications, genetics, kidney function, physical activity, diet and metabolic health can all affect testosterone or blood pressure. - Fatigue, changes in sexual function, mood, exercise tolerance and body composition can offer clues, but symptoms alone do not establish a diagnosis. - Obstructive sleep apnea can be associated with high blood pressure and other cardiovascular concerns. - Symptoms of sleep apnea can include loud snoring, witnessed pauses in breathing, morning headaches and excessive daytime sleepiness. - The TRAVERSE trial studied men with hypogonadism who had preexisting cardiovascular disease or increased cardiovascular risk. - The trial included 5,246 men ages 45 to 80 with symptoms of hypogonadism and two fasting testosterone measurements below 300 ng/dL. - Participants were randomly assigned to testosterone gel or placebo. - Testosterone therapy was noninferior to placebo for major adverse cardiovascular events in the study population. - Researchers also reported differences in certain adverse events between the groups. - Separate ambulatory blood pressure monitoring studies found increased blood pressure across testosterone products to varying degrees. - MOPE Clinic said a single elevated blood pressure reading does not necessarily mean chronic hypertension, and a single normal reading does not capture cardiovascular health over time. - Chris Rue, FNP-C, said testosterone care should look beyond one laboratory number and should include blood pressure, symptoms, medical history and follow-up. - Depending on the patient, monitoring may include blood pressure, hemoglobin and hematocrit because testosterone can stimulate red blood cell production in some patients. - Patients are being advised to keep an accurate medication list, organize prior lab results, write down symptoms before a visit and track sleep quality when relevant. - Patients who have been told to monitor blood pressure at home can record readings, dates and times, but home monitoring should not replace medical care or lead to self-directed medication changes. - MOPE Clinic says patients should not increase, decrease or stop testosterone or blood pressure medication based on online advice.

Between the lines: - The clinic is framing newer FDA guidance as an example of how medical evidence becomes more specific over time, not as a simple yes-or-no verdict on testosterone safety. - The message also reflects a broader shift away from treating testosterone as a single lab value and toward considering the whole clinical picture. - Sleep disorders, weight, metabolic health and cardiovascular risk can overlap with symptoms that prompt men to seek hormone testing in the first place. - That overlap can complicate diagnosis, which is why the clinic is emphasizing context before treatment decisions.

What's next: - Patients considering testosterone therapy are being urged to ask how low testosterone is evaluated, whether another health condition could explain symptoms and whether blood pressure or cardiovascular history changes treatment choices. - Patients may also want to ask which lab values will be monitored, how response to treatment will be measured and whether sleep issues should be addressed first. - MOPE Clinic says treatment selection and monitoring should be individualized by a licensed healthcare professional. - The clinic says evolving FDA safety information supports continued monitoring rather than one-size-fits-all testosterone care.